November 21, 2011 | Scion Hosts Symposium: Medical Devices in the Emerging Chinese Market
November 21, 2011 – Waltham, Massachusetts. Scion Medical Technologies co-hosted the symposium, “Medical Devices in the Emerging Chinese Market”. Scion and its co-host, CMC Group, the investment arm of China Medical City, a government backed life sciences economic zone in Taizhou, China, brought together a panel of leading medical device industry experts from the U.S. and China to discuss the business and regulatory climate for medical devices in the Chinese market. Panel members included officers from CMC Group, China’s SFDA (the equivalent of our FDA), Hologic, Evercore and 3SBio. The symposium was attended by executives, investors and services providers from both the Chinese and U.S. medical device industries.
About Scion Medical Technologies
Scion Medical Technologies (Scion) is a global medical device company with US headquarters in Massachusetts. Scion has manufacturing, distribution and regulatory expertise in the US and China, and is actively looking to grow its product portfolio by acquiring and licensing medical devices that have received 510(k) clearance or premarket approval from the FDA, or are CE-Marked.
About CMC Group
CMC Group is the investment arm of China Medical City (CMC). Headquartered in Taizhou, China, CMC is a state-funded, 30 square kilometer life sciences economic zone established to attract industry leaders from around the globe. CMC is the only state-funded life sciences zone in China.